The American Journal of Pathology
Volume 178, Issue 5 , Pages 2437-2446, May 2011

Physiological Contribution of CD44 as a Ligand for E-Selectin during Inflammatory T-Cell Recruitment

  • Maria Nácher

      Affiliations

    • Department of Epidemiology, Atherothrombosis and Imaging, Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain
  • ,
  • Ana Belén Blázquez

      Affiliations

    • Division of Pediatric Allergy and Immunology, Mount Sinai School of Medicine, New York, New York
  • ,
  • Bojing Shao

      Affiliations

    • University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma
  • ,
  • Adela Matesanz

      Affiliations

    • Department of Vascular Biology and Inflammation, Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain
  • ,
  • Colette Prophete

      Affiliations

    • Immunology Institute, Mount Sinai School of Medicine, New York, New York
    • Department of Medicine, Mount Sinai School of Medicine, New York, New York
  • ,
  • M. Cecilia Berin

      Affiliations

    • Department of Gene and Cell Medicine, Mount Sinai School of Medicine, New York, New York
    • Division of Pediatric Allergy and Immunology, Mount Sinai School of Medicine, New York, New York
  • ,
  • Paul S. Frenette

      Affiliations

    • Immunology Institute, Mount Sinai School of Medicine, New York, New York
    • Department of Medicine, Mount Sinai School of Medicine, New York, New York
    • Department of Gene and Cell Medicine, Mount Sinai School of Medicine, New York, New York
    • Black Family Stem Cell Institute, Mount Sinai School of Medicine, New York, New York
  • ,
  • Andrés Hidalgo

      Affiliations

    • Department of Epidemiology, Atherothrombosis and Imaging, Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain
    • Immunology Institute, Mount Sinai School of Medicine, New York, New York
    • Department of Medicine, Mount Sinai School of Medicine, New York, New York
    • Corresponding Author InformationAddress reprint requests to Andrés Hidalgo, PhD, Centro Nacional de Investigaciones Cardiovasculares, Calle Melchor Fernández Almagro, 3, Madrid, 28029 Madrid, Spain

Accepted 28 January 2011. published online 04 April 2011.

Endothelial selectins guide the migration of inflammatory T cells to extralymphoid tissues. Whereas P-selectin glycoprotein ligand-1 (PSGL-1) functions as the exclusive ligand for P-selectin, it acts in coordination with additional glycoproteins to mediate E-selectin binding. CD44 can act as one such ligand in neutrophils, but its contribution in inflammatory T lymphocytes remains unexplored. We have used real-time in vivo imaging of the cremasteric and dermal microcirculations to explore the dynamics of leukocyte recruitment, as well as the physiological contribution of CD44 in a model of Th1-driven inflammation. CD4+ T-cell rolling frequency and kinetics, as well as arrest, were dependent on endothelial selectins and were markedly altered under inflammatory conditions. CD44 extracted from Th1 cells bound to soluble E-selectin in vitro and cooperated with PSGL-1 by controlling rolling velocities and promoting firm arrest. Using several competitive recruitment assays in a delayed-type hypersensitivity model, we show that the combined absence of CD44 and PSGL-1 impairs inflammatory T-cell recruitment beyond that of PSGL-1 alone. Differential expression of leukocyte fucosyltransferases in these cells may account for the differential use of E-selectin ligands relative to neutrophils. Our results identify additional mechanisms by which CD44 modulates the inflammatory response.

 

 Supported by a Scientist Development grant from the American Heart Association to A.H. and U.S. National Institutes of Health grant R01 HL69438 to P.S.F (0735165N). A.H. is also supported by a Ramón y Cajal fellowship, a grant (SAF2009-11037) from the Spanish Ministry of Science and Innovation, and by a grant (246655) from the FP7-People-IRG Program. The Centro Nacional de Investigaciones Cardiovasculares is supported by the Spanish Ministry of Science and Innovation and the Pro-CNIC Foundation.

 Supplemental material for this article can be found at http://ajp.amjpathol.org or at doi: 10.1016/j.ajpath.2011.01.039.

 Current address of C.P. and P.S.F., Institute of Stem Cell Biology and Regenerative Medicine, Albert Einstein College of Medicine, New York, NY; of A.B.B., Fundación IMABIS, Malaga, Spain.

PII: S0002-9440(11)00148-9

doi:10.1016/j.ajpath.2011.01.039

The American Journal of Pathology
Volume 178, Issue 5 , Pages 2437-2446, May 2011